GS NX3 25 (Promacta 25 mg)
Generic Name: eltrombopag
Pill imprint GS NX3 25 has been identified as Promacta 25 mg.
Promacta is used in the treatment of aplastic anemia; idiopathic thrombocytopenic purpura; thrombocytopenia idiopathic; thrombocytopenia and belongs to the drug class platelet-stimulating agents. Risk cannot be ruled out during pregnancy. Promacta 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- GS NX3 25
- 25 mg
- Prescription only
- Drug Class:
- Platelet-stimulating agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- National Drug Code (NDC):
- Inactive Ingredients:
- magnesium stearate
sodium starch glycolate type A potato
polyethylene glycol 400
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|00078-0685||Novartis Pharmaceuticals Corporation|
Note: Inactive ingredients may vary.
More about Promacta (eltrombopag)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.